[ad_1]
Ozempic, the appetite-suppressing injection also referred to as semaglutide, presently costs $935.77 within the U.S. with out insurance coverage. However a new research report from Yale College, King’s Faculty Hospital in London, and Docs With out Borders revealed in JAMA Network Open Wednesday means that the worth of the prescription drug might be lowered to a fraction of what it’s proper now, whereas nonetheless producing a revenue.
The researchers calculated cost-based costs for one month of Ozempic, administered as an injectable of 0.77 mg weekly, by combining business commerce cargo information from January 1, 2016 to March 31, 2023 with the price of creating the drug, different working bills, a revenue margin, and tax. They discovered that the cost-based costs of Ozempic ranged from $0.89 to $4.73 per thirty days.
“The findings of this research counsel that insulins, SGLT2Is, and GLP1As can probably be manufactured for costs far beneath present costs, enabling wider entry,” the researchers wrote.
A pharmacist holds a field of Novo Nordisk A/S Ozempic model semaglutide remedy. Photographer: George Frey/Bloomberg through Getty Pictures
Ozempic prices much less outdoors of the U.S. — a Bloomberg report discovered {that a} month’s provide of the injectable prices beneath $300 in Mexico.
“Outdoors the US, nations have totally different regulatory necessities with regard to the pricing of medicines, together with negotiating with respective authorities entities,” Ozempic maker Novo Nordisk advised Bloomberg.
Associated: FDA Has Seized ‘Thousands’ of Fake Units of Ozempic Amid Reported Cases of ‘Adverse Reactions’ in Patients
Drug markups have lengthy come beneath nationwide scrutiny, with Martin Shkreli, the previous head of Turing Prescribed drugs, pressured to pay $64 million in 2022 after inflating the worth of a life-saving drug by 4,000%.
Ozempic falls beneath the class of a GLP-1 drug, that means that it addresses sort 2 diabetes by enhancing blood sugar management and likewise doubtlessly resulting in weight reduction, in keeping with the Mayo Clinic.
Prescriptions of GLP-1 medicine elevated by 300% between 2020 and 2022, Trilliant Health researchers discovered. Ozempic first made headlines in 2021 when it was featured on the Dr. Oz Present.
Associated: Novo Nordisk, the Maker of Ozempic, Is Suing Spas and Clinics For Allegedly Selling Knockoffs
Ozempic and different related medicine may trigger a mean weight lack of 15% to twenty%, “considerably increased than earlier choices,” as per Columbia Surgery.
The identical publication warns of the life-long dedication Ozempic requires, as discontinuing the drug may result in gaining the entire weight again. The drug may additionally trigger nausea, cramps, and different disagreeable negative effects.
Regardless of the excessive value and potential downsides, Ozempic skyrocketed in recognition final yr, with 66% of its greater than $13 billion gross sales coming from the US, in keeping with Novo Nordisk’s 2023 annual report.
Associated: Novo Nordisk Is Worth More Than Denmark’s GDP Thanks to America’s Ozempic and Wegovy Craze
[ad_2]
Source link
